Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Influenza

Free Subscription Articles published in Biochem Biophys Res Commun Retrieve available abstracts of 51 articles: HTML format

Single Articles

August 2025
1. FAN Z, Li J, He L, Li Q, et al
   Nanobody-based fluorescent immunoassay for SARS-CoV-2 spike detection via site-specific microbial transglutaminase labeling.
   Biochem Biophys Res Commun. 2025;775:152162.
   PubMed     Abstract available
   
   
   June 2025
2. PERFILOVA KV, Matyuta IO, Minyaev ME, Boyko KM, et al
   High-resolution structure reveals enhanced 14-3-3 binding by a mutant SARS-CoV-2 nucleoprotein variant with improved replicative fitness.
   Biochem Biophys Res Commun. 2025;767:151915.
   PubMed     Abstract available
   
   
   
3. KOU L, Wan Y, Nemoto YL, Tsujita K, et al
   Role of membrane proximal actin regulators in SARS-CoV-2 spike-induced cell-cell fusion.
   Biochem Biophys Res Commun. 2025;766:151846.
   PubMed     Abstract available
   
   
   
4. CHU X, Yang Y, Guo H, Ji X, et al
   SARS-CoV-2 NSP2 specifically interacts with cellular protein SmgGDS.
   Biochem Biophys Res Commun. 2025;764:151828.
   PubMed     Abstract available
   
   
   
5. ZHANG YH, Su AM, Hou XM
   Structural and functional insights into the SARS-CoV-2 SUD domain and its interaction with RNA G-Quadruplexes.
   Biochem Biophys Res Commun. 2025;764:151817.
   PubMed     Abstract available
   
   
   April 2025
6. LIU HL, Lin S, Hung W, Chang DC, et al
   A novel replicase-mediated self-amplifying RNA amplification mechanism of the SARS-CoV-2 replication-transcription system.
   Biochem Biophys Res Commun. 2025;758:151654.
   PubMed     Abstract available
   
   
   
7. ZABRODSKAYA YA, Gavrilova NV, Elpaeva EA, Lozhkov AA, et al
   Corrigendum to "mRNA encoding antibodies against hemagglutinin and nucleoprotein prevents influenza virus infection in vitro" [Biochem. Biophys. Res. Commun. 738 (2024) 150945].
   Biochem Biophys Res Commun. 2025 Apr 9:151783. doi: 10.1016/j.bbrc.2025.151783.
   PubMed    
   
   
   
8. GU L, Wang ZJ, Zhang XR, Liu Y, et al
   Targeting the liquid-liquid phase separation of nucleocapsid broadly inhibits the replication of SARS-CoV-2 strains.
   Biochem Biophys Res Commun. 2025;756:151594.
   PubMed     Abstract available
   
   
   
9. KOCHAROVSKAYA MV, Pichkur EB, Ivannikov AD, Kharlampieva DD, et al
   Structure and dynamics of Alpha B.1.1.7 SARS-CoV-2 S-protein in complex with Fab of neutralizing antibody REGN10987.
   Biochem Biophys Res Commun. 2025;755:151558.
   PubMed     Abstract available
   
   
   March 2025
10. IMBIAKHA B, Ezzatpour S, Buchholz DW, Poosala S, et al
    Novel nanobody drug conjugate as a prophylactic or therapeutic against SARS-CoV-2 infection in mice.
    Biochem Biophys Res Commun. 2025;753:151480.
    PubMed     Abstract available
    
    
    February 2025
11. DU S, Yang L, Chen X, Chen Y, et al
    Engineering mRNA vaccine with broad-spectrum protection against SARS-cov-2 variants.
    Biochem Biophys Res Commun. 2025;746:151224.
    PubMed     Abstract available
    
    
    January 2025
12. CULIAT C, Soni D, Malkes W, Wienhold M, et al
    NELL1 variant protein (NV1) modulates hyper-inflammation, Th-1 mediated immune response, and the HIF-1alpha hypoxia pathway to promote healing in viral-induced lung injury.
    Biochem Biophys Res Commun. 2025;744:151198.
    PubMed     Abstract available
    
    
    December 2024
13. HOSOKAWA K, Ohmori H
    Digital reverse transcription PCR using a simple poly(dimethylsiloxane) microwell array chip for detection of SARS-CoV-2.
    Biochem Biophys Res Commun. 2024;741:151070.
    PubMed     Abstract available
    
    
    
14. ROY A, Paul I, Paul T, Dihidar A, et al
    Exploring B-cell epitope conservation and antigenicity shift in current COVID-19 variants: Analyzing spike-antibody interactions for therapeutic uses.
    Biochem Biophys Res Commun. 2024;739:150948.
    PubMed     Abstract available
    
    
    
15. BEGUM F, Chandra S, Mallik MH, Dey J, et al
    A SARS-CoV-2 peptide antigen purified from bacteria and displayed in a high-density repetitive manner on a virus-like particle could generate anti-SARS-CoV-2 neutralizing antibodies unlike free peptide.
    Biochem Biophys Res Commun. 2024;739:150579.
    PubMed     Abstract available
    
    
    
16. ZHAN Y, Li M, Gong R
    Protein mimics of fusion core from SARS-CoV-1 can inhibit SARS-CoV-2 entry.
    Biochem Biophys Res Commun. 2024;736:150857.
    PubMed     Abstract available
    
    
    November 2024
17. SINGH V, Bhutkar M, Choudhary S, Nehul S, et al
    Structure-guided mutations in CDRs for enhancing the affinity of neutralizing SARS-CoV-2 nanobody.
    Biochem Biophys Res Commun. 2024;734:150746.
    PubMed     Abstract available
    
    
    
18. ZUBIETE-FRANCO I, Tonks NK
    Famotidine increases cellular phospho-tyrosine levels.
    Biochem Biophys Res Commun. 2024;734:150763.
    PubMed     Abstract available
    
    
    
19. VISSAPRAGADA M, Addala S, Aggunna M, Sodasani M, et al
    Leveraging the potential of bacterial lateral gene transfer in boosting the efficacy of an edible probiotic prototype yogurt vaccine for COVID-19.
    Biochem Biophys Res Commun. 2024;734:150622.
    PubMed     Abstract available
    
    
    
20. UCHIKUBO-KAMO T, Ishimoto N, Umezawa H, Hirohama M, et al
    Structural insights into Influenza A virus RNA polymerase PB1 binding to nuclear import host factor RanBP5.
    Biochem Biophys Res Commun. 2024;739:150952.
    PubMed     Abstract available
    
    
    
21. ZABRODSKAYA YA, Gavrilova NV, Elpaeva EA, Lozhkov AA, et al
    mRNA encoding antibodies against hemagglutinin and nucleoprotein prevents influenza virus infection in vitro.
    Biochem Biophys Res Commun. 2024;738:150945.
    PubMed     Abstract available
    
    
    September 2024
22. KUSHWAHA N, Dwivedi A, Tiwari S, Mishra P, et al
    Comprehensive analytics for virus-cell and cell-cell multinucleation system.
    Biochem Biophys Res Commun. 2024;726:150281.
    PubMed     Abstract available
    
    
    
23. LI Q, Zhou X, Wang W, Xu Q, et al
    Structural basis of rosmarinic acid inhibitory mechanism on SARS-CoV-2 main protease.
    Biochem Biophys Res Commun. 2024;724:150230.
    PubMed     Abstract available
    
    
    
24. XU J, Zhu Q, Li W, Yin X, et al
    Structural basis for the inhibition of the HCoV-NL63 main protease M(pro) by X77.
    Biochem Biophys Res Commun. 2024;724:150231.
    PubMed     Abstract available
    
    
    July 2024
25. TACHIBANA K, Nakamura Y, Do TL, Kihara T, et al
    Mutations in the SARS-CoV-2 spike proteins affected the ACE2-binding affinity during the development of Omicron pandemic variants.
    Biochem Biophys Res Commun. 2024;719:150120.
    PubMed     Abstract available
    
    
    
26. GAUR NK, Urankar S, Sengupta D, Chepuri VR, et al
    A cell based assay using virus-like particles to screen AM type mimics for SARS-CoV-2 neutralisation.
    Biochem Biophys Res Commun. 2024;718:150082.
    PubMed     Abstract available
    
    
    
27. KULMA M, Sakanovic A, Bedina-Zavec A, Caserman S, et al
    Sequestration of membrane cholesterol by cholesterol-binding proteins inhibits SARS-CoV-2 entry into Vero E6 cells.
    Biochem Biophys Res Commun. 2024;716:149954.
    PubMed     Abstract available
    
    
    June 2024
28. BAI G, Zeng X, Zhang L, Wang Y, et al
    Computational investigation of the inhibitory interaction of IRF3 and SARS-CoV-2 accessory protein ORF3b.
    Biochem Biophys Res Commun. 2024;712-713:149945.
    PubMed     Abstract available
    
    
    
29. KAWAI A, Hirata H, Tokunoh N, Ono C, et al
    Adjuvant-free parenterally injectable vaccine platform that harnesses previously induced IgG as an antigen delivery carrier.
    Biochem Biophys Res Commun. 2024;711:149919.
    PubMed     Abstract available
    
    
    May 2024
30. KALASHNYK O, Lykhmus O, Sullivan R, Komisarenko S, et al
    Agonists or positive allosteric modulators of alpha7 nicotinic acetylcholine receptor prevent interaction of SARS-Cov-2 receptor-binding domain with astrocytoma cells.
    Biochem Biophys Res Commun. 2024;709:149825.
    PubMed     Abstract available
    
    
    
31. SU L, Lou Y, Li J, Mao H, et al
    Influence of storage solution, temperature, assay time and concentration on RT-qPCR nucleic acid detection for SARS-CoV-2 detection of SARS-CoV-2 by the RT-qPCR.
    Biochem Biophys Res Commun. 2024;707:149726.
    PubMed     Abstract available
    
    
    April 2024
32. KOMU JG, Jamsransuren D, Matsuda S, Ogawa H, et al
    Collection and transportation of SARS-CoV-2 and influenza A virus diagnostic samples: Optimizing the usage of guanidine-based chaotropic salts for enhanced biosafety and viral genome preservation.
    Biochem Biophys Res Commun. 2024;715:149994.
    PubMed     Abstract available
    
    
    March 2024
33. HE K, Ye Y, Liu S, Yuan P, et al
    Polylevodopa nanoplatform for lateral flow immunochromatography assay of SARS-CoV-2 and influenza A virus.
    Biochem Biophys Res Commun. 2024;709:149821.
    PubMed     Abstract available
    
    
    
34. KIM HJ, Han CW, Jeong MS, Jang SB, et al
    Cryo-EM structure of Influenza A virus NS1 and antiviral protein kinase PKR complex.
    Biochem Biophys Res Commun. 2024;706:149728.
    PubMed     Abstract available
    
    
    January 2024
35. SAITO T, Couzinet A, Murakami T, Shimomura M, et al
    Rapid and high throughput assessment of cellular immunity against SARS-CoV-2 based on the ex vivo activation of genes in leukocyte assay with whole blood.
    Biochem Biophys Res Commun. 2024;694:149398.
    PubMed     Abstract available
    
    
    
36. NASSAR K, El-Mekawey D, Elmasry AE, Refaey MS, et al
    The significance of caloric restriction mimetics as anti-aging drugs.
    Biochem Biophys Res Commun. 2024;692:149354.
    PubMed     Abstract available
    
    
    
37. JIANG H, Zou X, Zhou X, Zhang J, et al
    Crystal structure of SARS-CoV-2 main protease (M(pro)) mutants in complex with the non-covalent inhibitor CCF0058981.
    Biochem Biophys Res Commun. 2024;692:149352.
    PubMed     Abstract available
    
    
    December 2023
38. KAWAHARA E, Yamamoto S, Shibata T, Hirai T, et al
    CpG ODN enhances the efficacy of F protein vaccine against respiratory syncytial virus infection in the upper respiratory tract via CD4(+) T cells.
    Biochem Biophys Res Commun. 2023;686:149143.
    PubMed     Abstract available
    
    
    
39. ZHANG L, Zhang X, Deng X, Wang P, et al
    Cytokines as drivers: Unraveling the mechanisms of epithelial-mesenchymal transition in COVID-19 lung fibrosis.
    Biochem Biophys Res Commun. 2023;686:149118.
    PubMed     Abstract available
    
    
    November 2023
40. CARONIA L, Xi R, Margolskee RF, Jiang P, et al
    Paxlovid mouth likely is mediated by activation of the TAS2R1 bitter receptor by nirmatrelvir.
    Biochem Biophys Res Commun. 2023;682:138-140.
    PubMed     Abstract available
    
    
    October 2023
41. JIANG S, Yang H, Sun Z, Zhang Y, et al
    The basis of complications in the context of SARS-CoV-2 infection: Pathological activation of ADAM17.
    Biochem Biophys Res Commun. 2023;679:37-46.
    PubMed     Abstract available
    
    
    
42. FRASER-PITT D, Mercer DK, Francis ML, Toledo-Aparicio D, et al
    Cysteamine-mediated blockade of the glycine cleavage system modulates epithelial cell inflammatory and innate immune responses to viral infection.
    Biochem Biophys Res Commun. 2023;677:168-181.
    PubMed     Abstract available
    
    
    
43. YAO Y, Zhang Y, Li Z, Chen Z, et al
    A deep learning-based drug repurposing screening and validation for anti-SARS-CoV-2 compounds by targeting the cell entry mechanism.
    Biochem Biophys Res Commun. 2023;675:113-121.
    PubMed     Abstract available
    
    
    September 2023
44. FUJISAWA M, Adachi Y, Onodera T, Shiwa-Sudo N, et al
    High-throughput isolation of SARS-CoV-2 nucleocapsid antibodies for improved antigen detection.
    Biochem Biophys Res Commun. 2023;673:114-120.
    PubMed     Abstract available
    
    
    August 2023
45. SUN W, Zhang Z, Chen M, Liu X, et al
    Discovery of a potent inhibitor targeting the cap-binding domain of the PB2 subunit of influenza RNA-dependent RNA polymerase.
    Biochem Biophys Res Commun. 2023;678:97-101.
    PubMed     Abstract available
    
    
    
46. YU J, Im H, Lee G
    Unwinding mechanism of SARS-CoV helicase (nsp13) in the presence of Ca(2+), elucidated by biochemical and single-molecular studies.
    Biochem Biophys Res Commun. 2023;668:35-41.
    PubMed     Abstract available
    
    
    July 2023
47. BEAUDOIN CA, Petsolari E, Hamaia SW, Hala S, et al
    SARS-CoV-2 Omicron subvariant spike N405 unlikely to rapidly deamidate.
    Biochem Biophys Res Commun. 2023;666:61-67.
    PubMed     Abstract available
    
    
    June 2023
48. ISHII H, Jounai K, Tsuji R, Ohshio K, et al
    Plasmacytoid dendritic cells stimulated with Lactococcus lactis strain Plasma produce soluble factors to suppress SARS-CoV-2 replication.
    Biochem Biophys Res Commun. 2023;662:26-30.
    PubMed     Abstract available
    
    
    
49. CHU X, Ding X, Yang Y, Lu Y, et al
    Mechanism of an RBM-targeted rabbit monoclonal antibody 9H1 neutralizing SARS-CoV-2.
    Biochem Biophys Res Commun. 2023;660:43-49.
    PubMed     Abstract available
    
    
    May 2023
50. ITO K, Goto K, Shirakawa R, Horiuchi H, et al
    Platelet alphaIIbbeta3 integrin binds to SARS-CoV-2 spike protein of alpha strain but not wild type and omicron strains.
    Biochem Biophys Res Commun. 2023;657:80-85.
    PubMed     Abstract available
    
    
    
51. ZHOU Y, Wang W, Zeng P, Feng J, et al
    Structural basis of main proteases of HCoV-229E bound to inhibitor PF-07304814 and PF-07321332.
    Biochem Biophys Res Commun. 2023;657:16-23.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Influenza is free of charge.